Investigator(s):
The Lundquist Institute
LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain.
Investigator(s):
Matthew Budoff, MD
LA BioMed was recently accredited for various research programs. Dr. Matthew Budoff is leading one such study on testosterone and its effect on the hearts of patients. (Robert Casillas / Staff Photographer)
Carlos Portillo visited LA BioMed this week, just as he has done regularly for two years, for a round of blood tests and probing questions.
Portillo, who is HIV-positive, is participating in one of the research center’s 200 ongoing clinical trials, testing a combination of medications so doctors can determine what pairings work best.
Investigator(s):
The Lundquist Institute
Bisphenol A, better known as BPA, was recently banned in baby bottles but the FDA stopped short of completely nixing the chemical.
A common chemical found in the lining of water bottles, aluminum cans and other food packaging may put children at risk of developing kidney and heart disease, according to a study from the NYU School of Medicine.
Researchers analyzed data on more than 700 children, focusing on the amount of Bisphenol A, better known as BPA, in their urine.
Investigator(s):
The Lundquist Institute
LOS ANGELES (Dec. 13, 2012) – The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), recognized as a leader in groundbreaking medical advancements and for bringing laboratory discoveries from the bench to the bedside, recently received accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). LA BioMed was one of five entities whose accreditation was approved at the meeting of AAHRPP’s Council on Accreditation in December.
Investigator(s):
Richard Casaburi, PhD, MD
LOS ANGELES (Nov. 13, 2012) – Chronic obstructive pulmonary disease, or COPD, is a progressive disease of the lungs that affects approximately 24 million people in the United States and is now the third leading cause of death in this country. For those who suffer from severe COPD, shortness of breath and other symptoms can make it difficult to perform simple tasks such as doing light housework, taking a walk, or even getting dressed.
Investigator(s):
The Lundquist Institute
H. Frederick Christie, the Ryan Foundation, and Susan Scott Foundation to be Honored
LOS ANGELES (Nov. 9, 2012) – The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) will celebrate six decades of achievements in turning innovative science into breakthrough medicine for patients in need at its Gift of Tomorrow Gala, on Thursday, Dec. 6, at the Beverly Wilshire Hotel in Beverly Hills, Calif.
Investigator(s):
Mallory Witt, MD, Carol D Berkowitz, MD
LOS ANGELES – (May 28, 2013) – Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their “outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching,” according to the David Geffen School of Medicine at UCLA, which presented the awards.